Medicus Pharma Ltd.

2.3000-0.11 (-4.56%)

Oct 29, 4:00:01 PM EDT · NasdaqCM · MDCX · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

49.35M

P/E (TTM)

Basic EPS (TTM)

-1.31

Dividend Yield

Recent Filings

8-K

10/17/25Oct 17, 2025

8-K

9/18/25Sep 18, 2025

8-K

9/12/25Sep 12, 2025

8-K

9/2/25Sep 2, 2025

8-K

8/22/25Aug 22, 2025

About

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.

CEO

Dr. Raza Bokhari M.B.A., M.D., MBA

IPO

11/14/2024

Website

https://medicuspharma.com

Sector

Healthcare

Industry

Drug Manufacturers - General